ARCHIVES

Committee Unblinds Phase III Zytiga Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI CTEP Last Month

January 28, 2011

Clinical Study Group Proposed To Examine Peer Review System

October 15, 1993

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

March 25, 2011

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

In Brief: Satcher Confirmed For U.S. Surgeon General; Bishop Selected As Chancellor Of UCSF

February 13, 1998

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996